Speaker
Networking Hours
Sessions
Attendees
MarketsandMarkets is providing a platform for pharmaceutical, biotechnology professionals and technology providers to come together at the BioGeNe 2022 Confex on the 16th - 17th June 2022 in San Diego-USA to discuss advancements and solutions to the most critical challenges in the Biomarker, Microbiome and Genome engineering areas.
With growing pressures of increasing success rates for FDA approved biomarkers as well as companion diagnostics tests has seen an outgrowth in drug discovery companies to invest in novel strategies for biomarker discovery. The industry of genome editing has witnessed some great breakthroughs during a year in the areas like genome writing, base editing and specific progression in the field of therapeutics through the Car-T cells and immunotherapy. With the increasing focus on the development of human microbiome therapies and probiotics product &drug development various small innovative players are operating in the market.
The three conferences which are going to be a part of Biogene Confex 2022 are, 7th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference and 4th Annual MarketsandMarkets Next-Gen Microbiome and Probiotics Conference
Vice President, Head, Translational Medicine, , Syncopation Lifesciences
Founder, CEO, Scaled Microbiomics
CEO, Primal Health Inc.
CEO, Phi Therapeutics
CEO and Founder, Cybele Microbiome
Director, Molecular Biology & Sequencing, Gritstone Oncology, Inc.
Assistant Research Scientist, University of California Santa Cruz
Assistant Professor, University of California, San Diego
Professor, Innovation Lead Digital Health, Cleveland Clinic
Senior Research Student, University of Michigan
Professor, Boston University School of Medicine
Associate Research Scientist, New York University
University of Florida, Research Assistant Scientist
Director, Bioinformatics and Systems Biology Shared Resource, Winship Cancer Institute
Director, Institute for Genomic Medicine, University of California, San Diego
Chief Scientific Officer, M2B Pharma
Investment Advisor, Seventure
CEO & Founder, Biosortia Pharmaceuticals
Associate Director, Microbial Development Team, Takeda Pharmaceuticals
Executive Director, Precision Medicine Leader, Novartis
Senior Medical Director , Viracta Therapeutics, Inc.
Senior Vice President, Quantitative & Computational Biology , RAPT Therapeutics
Vice President, Head, Translational Medicine, , Syncopation Lifesciences
Medical Director, Oncology CDx and Biomarkers, Amgen
Vice President, Innovation Partnerships, Cardea Bio
Program Director, Breast and GYN Cancers, and Bioinformatics, NCI, NIH
Head, Molecular Biomarkers & Genomics, EMD Serono
Biomarker Clinical Assay Lead, Manager, Pfizer
Scientific Director, Translational Biomarker Research , Takeda
Assistant Professor, University of California, San Diego
Assistant Research Scientist, University of California Santa Cruz
Director, Molecular Biology & Sequencing, Gritstone Oncology, Inc.
CEO and Founder, Cybele Microbiome
CEO, Phi Therapeutics
CEO, Primal Health Inc.
Founder, CEO, Scaled Microbiomics
Double Tree by Hilton San Diego- Mission Valley
